ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663,932 | -5.3% | 9,804 | +0.1% | 0.22% | -3.4% |
| Q2 2023 | $701,132 | +5.7% | 9,796 | +2.5% | 0.23% | -4.1% |
| Q1 2023 | $663,383 | +26.8% | 9,557 | +0.2% | 0.24% | -2.0% |
| Q4 2022 | $523,258 | +0.0% | 9,542 | 0.0% | 0.25% | +0.4% |
| Q3 2022 | $523,000 | -20.2% | 9,542 | -3.9% | 0.25% | -30.7% |
| Q2 2022 | $655,000 | -0.6% | 9,928 | 0.0% | 0.36% | +8.2% |
| Q1 2022 | $659,000 | +27.0% | 9,928 | +11.4% | 0.33% | +26.2% |
| Q4 2021 | $519,000 | -3.0% | 8,912 | 0.0% | 0.26% | -14.2% |
| Q3 2021 | $535,000 | +5.5% | 8,912 | +0.5% | 0.30% | +7.1% |
| Q2 2021 | $507,000 | +469.7% | 8,865 | +395.8% | 0.28% | +379.7% |
| Q1 2021 | $89,000 | +1.1% | 1,788 | +1.1% | 0.06% | -10.6% |
| Q4 2020 | $88,000 | -38.0% | 1,768 | -44.6% | 0.07% | -54.8% |
| Q1 2020 | $142,000 | – | 3,191 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |